Published: Guidance, quality standards and advice

Showing 11 to 20 of 20

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Immune (idiopathic) thrombocytopenic purpura: rituximab	ESUOM35	21 October 2014	21 October 2014
Non-Hodgkin's lymphoma: rituximab subcutaneous injection	ESNM46	9 September 2014	9 September 2014
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis	TA308	26 March 2014	26 March 2014
Rituximab for the first-line treatment of stage III-IV follicular lymphoma	TA243	25 January 2012	25 January 2012
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma	TA226	22 June 2011	22 June 2011
Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal)	TA206	27 October 2010	27 October 2010
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor	TA195	25 August 2010	25 August 2010
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia	TA193	28 July 2010	28 July 2010
Rituximab for the first-line treatment of chronic lymphocytic leukaemia	TA174	22 July 2009	22 July 2009
Rituximab for the treatment of relapsed or refractory stage 3 or 4 follicular non-Hodgkin's lymphoma	TA137	27 February 2008	27 February 2008